For years, Roche has been increasing medicine production in the United States. That could pay off for the drug maker as ...

Roche is set to invest $50bn in pharmaceuticals and diagnostics in the US over the coming five years to bolster its presence ...

Roche has become the latest major drugmaker to announce a significant investment in the US, committing $50bn into the country ...

More: Roche pours $50 billion into U.S. manufacturing; at least one new plant will be in Indiana Roche Diagnostics solidified its North American headquarters in Indianapolis in 1998 and has ...

The Indianapolis-based drugmaker also reaffirmed its 2025 revenue guidance but noted that the calculation was based on existing tariff and trade policies.

Executives at some of the world's biggest companies are faced with the tricky task of explaining how President Donald Trump's ...

The 2025 NFL Draft is in the books, and the New England Patriots were quite busy during draft weekend. They made 11 picks, ...

Novo Nordisk saw a significant decline as it lost over 55% from its highs in June 2024. Check out the reasons for the decline ...

President Trump wants to bring manufacturing back to the U.S. These companies say they're investing in domestic factories.

Roche has said it will spend $50 billion on ... for innovative medicines and diagnostics in Arizona, Kentucky, Indiana, New Jersey, Oregon, and California. All told, the investment programme ...

Wall Street powered to its second-best weekly advance of 2025 on Friday, with the benchmark S&P 500 (SP500) jumping nearly 5%. For the week, the S&P advanced +4 ...